SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!
Idera Pharmaceuticals, Inc.(NASDAQ : IDRA)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Loading IDRA News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-3.07%||73.50||1.1%||$645.43m|
|REGN||Regeneron Pharmaceuticals, Inc.||-4.00%||350.75||3.8%||$213.71m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.27%||133.04||2.4%||$197.22m|
|VRTX||Vertex Pharmaceuticals Incorporated||0.93%||76.54||2.6%||$142.36m|
|SRPT||Sarepta Therapeutics, Inc.||1.50%||41.42||18.7%||$134.91m|
|CLVS||Clovis Oncology, Inc.||-3.40%||29.82||31.6%||$97.90m|
|BMRN||BioMarin Pharmaceutical Inc.||0.00%||81.02||4.4%||$88.89m|
|ALNY||Alnylam Pharmaceuticals, Inc||-1.15%||35.80||10.0%||$82.39m|
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in discovery, development and commercialization of novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. Idera's immunotherapy approach is based on the modulation of toll-like receptors (TLRs) while its third-generation antisense technology is designed to inhibit the production of disease-associated proteins by targeting RNA. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal and James B. Wyngaarden in May 25, 1989 and is headquartered in Cambridge, MA.